Luminist Labs
YC W16 · Acquired · Diagnostic platform for early detection of liver disease
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS17 | |
| Other | Active | YC +1W20 | |
| Other | Active | YCS21 | |
| Other | Public | YC +1S17 | |
| Other | Not stated | EF2020 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW21 | |
| Other | Acquired | YCS20 | |
| Other | Inactive | YCS16 | |
| Other | Active | YC +1W22 | |
| Other | Active | YCW17 |
Also from W16
All of W16About Luminist Labs
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
- YC batch
- W16 · Winter 2016
- Status, per YC
- Acquired
- Category
- Other
- Team size
- 2
- Location
- New York City, NY, USA
- Checked
- 34m ago
YC tags: Medical Devices, Diagnostics, Genomics
Luminist Labs: questions
Which YC batch was Luminist Labs in?
Luminist Labs was in Y Combinator's Winter 2016 batch (W16).
Is Luminist Labs still active?
Y Combinator lists Luminist Labs as acquired.
Where is Luminist Labs based?
Luminist Labs lists New York City, NY, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.